Iris Diseases: Clinical Trials

6 trials for Iris Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 recruiting. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 3, Not yet recruiting 2, Recruiting 1

Follow Iris Diseases: new trials by email Literature Review of Iris Diseases trials Research Report on Iris Diseases

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Silodosin
Phase 4Not yet recruitingMohsen Pourazizi402026-08-012026-08-03
Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Tamsulosin
Phase 4Not yet recruitingMohsen Pourazizi402026-08-012026-08-03
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
iStent infinite trabecular micro-bypass system model iS3, iDose TR (Travoprost intracameral Implant) 75mcg - Open Angle Glaucoma, Pigmentary Glaucoma
Phase 4RecruitingJonathon Myers202026-01-052025-11-14
Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery
Dexamethasone+Tobramycin eye drop, Bromfenac eye drop - Cataract, Pseudoexfoliation Syndrome
Phase 4CompletedAzienda USL Reggio Emilia - IRCCS622013-11-012025-06-11
Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties
Polylens EC-HY10-PAL (coated), Polylens EC-Y10-PAL (uncoated) - Cataract, Diabetes
Phase 4CompletedVienna Institute for Research in Ocular Surgery402010-08-012013-01-11
Assessing Cosopt Switch Patients
timolol maleate, dorzolamide/timolol maleate fixed combination - Ocular Hypertension, Open-Angle Glaucoma
Phase 4CompletedPharmaceutical Research Network602005-11-012008-11-19

Narrower conditions

Exfoliation Syndrome (4)  ·  Cataract (2)  ·  Glaucoma, Open-Angle (2)  ·  Prostatic Hyperplasia (2)  ·  Diabetes Mellitus (1)  ·  Ocular Hypertension (1)

Broader conditions

Eye Diseases (6)  ·  Uveal Diseases (6)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Glaucoma (2)  ·  Lens Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Ocular Hypertension (1)

Interventions

Tamsulosin (2)  ·  silodosin (2)  ·  Timolol (1)  ·  dorzolamide (1)

Sponsors

Mohsen Pourazizi (2)  ·  Azienda USL Reggio Emilia - IRCCS (1)  ·  Jonathon Myers (1)  ·  Pharmaceutical Research Network (1)  ·  Vienna Institute for Research in Ocular Surgery (1)

Countries

United States (2)  ·  Austria (1)  ·  Italy (1)

Top investigators

Dilru Amarasekera, MD (1)  ·  Douglas G. Day, MD (1)  ·  Elizabeth D. Sharpe, MD (1)  ·  J. Charles Henry, MD (1)  ·  Luigi Fontana, MD PhD (1)  ·  Marco Coassin, MD PhD (1)  ·  Mark J. Weiss, MD (1)  ·  Mohsen Pourazizi (1)  ·  Mohsen Pourazizi, Assistant Professor (1)  ·  Sriram Sonty, MD, FACS (1)  ·  William C. Stewart, MD (1)